Marshall Wace, LLP Renalytix PLC Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.45 - $7.81 $104,284 - $332,432
-42,565 Reduced 66.32%
21,615 $53,000
Q1 2022

May 16, 2022
BUY
$5.88 - $15.9 $228,602 - $618,160
38,878 Added 153.66%
64,180 $444,000
Q4 2021

Feb 14, 2022
BUY
$13.43 - $27.4 $339,805 - $693,274
25,302 New
25,302 $403,000

Others Institutions Holding RNLX

# of Institutions
29
Shares Held
3.91M
Call Options Held
13.7K
Put Options Held
0
View Full List

About Renalytix plc

RNLX Quotes by TradingView
  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email